Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally available Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It also develops NX-0255, a CBL-B inhibitor for ex vivo use to enhance adoptive T-cell therapy; and DeTIL-0255 that is in the Phase 1 clinical trial for the treatment of gynecologic cancers, including ovarian, endometrial, and cervical cancer. The company has a strategic collaboration agreement with Gilead Sciences, Inc. for cancer and other challenging diseases patients; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. The company was incorporated in 2009 and is headquartered in San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Nurix Therapeutics Inc..
Nurix Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Nurix Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Nurix Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Nurix Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Nurix Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Nurix Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Nurix Therapeutics Inc.- Key Facts
2.2 Nurix Therapeutics Inc.- Geographic Locations
2.3 Nurix Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Nurix Therapeutics Inc.- Business Divisions
2.5 Nurix Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Nurix Therapeutics Inc. Strategic Analysis Review
3.1 Nurix Therapeutics Inc.- Key Strategies
3.2 Nurix Therapeutics Inc.- Company Outlook Statement
3.3 Nurix Therapeutics Inc.- SWOT Analysis
3.3.1 Nurix Therapeutics Inc.- Key Strengths
3.3.2 Nurix Therapeutics Inc.- Key Weaknesses
3.3.3 Nurix Therapeutics Inc.- Potential Opportunities
3.3.4 Nurix Therapeutics Inc.- Potential Threats
3.4 Nurix Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Nurix Therapeutics Inc.- Business Overview
4.2 Nurix Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Nurix Therapeutics Inc.- Key Products
5.2 Nurix Therapeutics Inc.- Key Service Areas
5.3 Nurix Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Nurix Therapeutics Inc.- Company History
6.2 Nurix Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Nurix Therapeutics Inc.- Income Statements
7.2 Nurix Therapeutics Inc.- Balance Sheet
7.3 Nurix Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Nurix Therapeutics Inc.- Direct Competitors
8.2 Nurix Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Nurix Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Nurix Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
